M i t is a start-up company based in San Francisco. It's developing new ways of making drugs using plant natural products. The lab was set up by one of its cofas, an old school fer scientist called tom knight. Yel tells us about the automation that has occurred and how much faster you can go to day than maybe five years ago or ten years ago.
First Jason explains how to deliver great investor updates & the benefits of doing them well (1:36). Then, Ginkgo Bioworks CEO Jason Kelly joins to discuss the expanding capabilities of synthetic biology (24:48), how Ginkgo is currently helping customers make products more effectively (35:58), the ethics & risks of editing DNA (51:53) & more!